Companies / Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc.
Nasdaq: PCSACIK 1533743VERO BEACH, FL
Insider flow · last 90 daysNet buys $21.0K
Financials · FY2022
Ownership
2.8M shares outstanding · as of May 1, 2026
Ownership
| Insiders | 1.37% | 37,576 |
| Institutions | 4.54% | 124,759 |
| Public float | 94.10% | 2,587,838 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 6
View all →| Insider | % of shares | Shares |
|---|---|---|
Young DavidPres. Research & Development · Director | 0.70% | 19,198 |
Skibsted RussellChief Financial Officer | 0.49% | 13,412 |
Lin PatrickChief Business - Strategy Off | 0.06% | 1,753 |
Bigora SianChief Development Officer | 0.06% | 1,604 |
Guy WendyChief Administrative Officer | 0.05% | 1,256 |
Yorke Justin WDirector | 0.01% | 353 |
Institutional holders 10
View all →| Holder | Value | % of shares |
|---|---|---|
| $86.9K | 1.10% | |
| $67.9K | 0.86% | |
| $62.8K | 0.91% | |
| $36.4K | 0.46% | |
| $35.5K | 0.45% | |
| $4.0K | 0.05% | |
| $56 | 0.72% | |
| $52 | <0.01% | |
| $20 | <0.01% | |
| $17 | <0.01% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | Skibsted Russell Executive | Buy | Common Stock | $5.9K | +2K +30.61% | 8,466 0.31% of shares | low |
| Apr 15, 2026 | Skibsted Russell Executive | Buy | Common Stock | $5.9K | +2K +85.37% | 4,308 0.16% of shares | low |
| Jun 15, 2026 | Skibsted Russell Executive | Buy | Common Stock | $5.9K | +3K +24.67% | 13,412 0.49% of shares | low |
| Mar 31, 2026 | Skibsted Russell Executive | Buy | Common Stock | $5.9K | +2K | 2,324 0.08% of shares | low |
| Apr 30, 2026 | Skibsted Russell Executive | Buy | Common Stock | $5.9K | +2K +50.84% | 6,498 0.24% of shares | low |
| May 29, 2026 | Skibsted Russell Executive | Buy | Common Stock | $5.9K | +2K +27.07% | 10,758 0.39% of shares | low |
| May 29, 2026 | Young David Executive | Buy | Common Stock | $4.6K | +2K +11.64% | 17,131 0.62% of shares | low |
| Apr 30, 2026 | Young David Executive | Buy | Common Stock | $4.6K | +2K +14.09% | 13,813 0.50% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Mitchell P. Kopin | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| PCSA | Common Stock | 74275C403 |